Companies

Indivior Pharmaceuticals, Inc.

INDV · CIK 0001625297 · operating

$31.98-2.26%Last updated Mar 2, 11:26 PM

Key Statistics

Valuation

Market Cap$4.00B
P/E32.63
Fwd P/E9.45
PEG
P/S3.23
P/B
EV/EBITDA10.47
EV/Rev3.35

Profitability

Gross Margin80.23%
Op. Margin21.15%
Net Margin16.95%
ROE-214.29%
ROA17.49%
FCF Margin-7.51%

Financial Health

Current Ratio0.71
Debt/Equity-13.27
Free Cash Flow-$93.00M
Div. Yield

Growth & Other

Revenue Growth4.29%
EPS Growth8100.00%
Beta1.19
52W High$38
52W Low$8.64

About Indivior Pharmaceuticals, Inc.

Indivior Pharmaceuticals, Inc. (INDV) is a pharmaceutical preparations company incorporated in DE, listed on the Nasdaq. With a market capitalization of $4.0 billion, Indivior Pharmaceuticals, Inc. is a mid-cap company. The stock currently trades at $31.98, down 2.26% today, with a 52-week range of $8.64–$38.00. The company trades at a trailing P/E of 32.6x and a forward P/E of 9.4x.

Earnings Per Share (Annual · SEC XBRL)

Fiscal years are as reported by the company and may not align with the calendar year. For example, Apple's FY 2024 ends in September 2024.

Fiscal YearEPS DilutedEPS BasicYoY
2025$1.64$1.68+8100.0%
2024$0.02$0.02

Annual Reports (10-K) · 2 filings

Report DateFiledAccession Number
2025-12-312026-02-260001628280-26-012237SEC ↗
2024-12-312025-03-030001625297-25-000016SEC ↗